Ibrance and Shortness Of Breath: What Users Say
Reviews for Ibrance
- Nel...
- May 9, 2017
For Breast Cancer, Metastatic "Diagnosed with Mets to lung and bones. Aggressive chemo worked for eight months, and then I was moved to Femara and Ibrance. Had to pay for the drug out of pocket because I'm not insured, and it cost us a king's ransom. This money could and should have been better spent. Ibrance wiped out my immune system and spread my cancer. After two months, I complained about breathlessness, but my oncologist assumed that we should give it some more time to work because of the promotional reviews and propaganda by Pfizer. I hate how the pharma industry is devouring our savings. They should not overrate their products and misguide oncologists. I don't know how they report results. I doubt that I will ever be counted among the failed cases. Very angry and disappointed."
- Bjc...
- Taken for 1 to 6 months
- November 1, 2021
For Breast Cancer, Metastatic "I was originally diagnosed in 2018. Was told that 4 rounds of chemo and had a bilateral mastectomy. My cancer was in my left nipple, and it was like deteriorating and separating from my breast, very itchy. I had surgery along with cosmetic surgery. Fast forward to 2021, and I had a severe cough, turns out it was double pneumonia with fluid development in my lungs. I had to have my lungs drained, eventually having a lung catheter implanted. From the fluid, they found some cancerous cells there. Some spots in my lungs and liver with this crazy cough. I started to see an oncologist and was diagnosed with MBC. I asked if there was a pill because I was not ready mentally to do chemo. She told me about Ibrance and Faslodex. I started in June, and so far, I am doing well. I was on 125 mg, reduced to 100 mg. Side effects: low blood count. I get really short of breath to the point where it’s hard to walk."
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Frequently asked questions
- How long does Ibrance extend life?
- Will insurance pay for the cost of Ibrance?
- What are 10 key Ibrance side effects to watch out for?
- Is Verzenio better than Ibrance?
Are you taking this medicine?
Your review helps others make informed decisions.More about Ibrance (palbociclib)
- Ibrance consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (85)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: CDK 4/6 inhibitors
- Breastfeeding
- En español
For Breast Cancer, Metastatic "Diagnosed with MBC in February 2014! In breast and sacrum. Started Femara only, no progression till October 2015! Spread to two ribs and spine. Started Ibrance with Femara and scans got better and better until 2 months ago, scan showed no hot spots!! As far as I'm concerned, in remission!!! Side effects: hair loss, no taste, tired all the time, severe hot flashes, shortness of breath, joint pain, but I can live with it all!! Thank you Pfizer and everyone involved in the studies who lived and died so I may live longer!"